CIK 0000200406 · Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221024240
- Phone
- 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,898,386
- in 3 filings
Net −$16,898,386. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-22 | Duato Joaquin CEO and Chairman of the Board | Option exercise · Employee Stock Options (Right to Buy) | −125,824 | $101.87 | $12.8M | 0 |
| 2025-08-15 | Wolk Joseph J Exec VP, CFO | Option exercise | +16,820 | $101.87 | $1.7M | 30,820 |
| 2025-08-15 | Wolk Joseph J Exec VP, CFO | Sale | −16,820 | $176.91 | $3.0M | 14,000 |
| 2025-08-15 | Wolk Joseph J Exec VP, CFO | Option exercise · Employee Stock Options (Right to Buy) | −16,820 | $101.87 | $1.7M | 0 |
| 2025-07-17 | REED JOHN C EVP, Innovative Medicine, R&D | Sale | −19,137 | $163.55 | $3.1M | 10,658 |
| 2025-06-10 | HEWSON MARILLYN A Director | Grant or award · Deferred Share Units | +322.1 | $155.23 | $50K | 13,437.98 |
| 2025-06-10 | Woods Eugene A. Director | Grant or award · Deferred Share Units | +231.32 | $155.23 | $36K | 4,597.24 |
| 2025-05-01 | REED JOHN C EVP, Innovative Medicine, R&D | Option exercise | +25,255 | 40,797 | ||
| 2025-05-01 | REED JOHN C EVP, Innovative Medicine, R&D | Shares withheld for taxes | −11,002 | $156.31 | $1.7M | 29,795 |
| 2025-05-01 | REED JOHN C EVP, Innovative Medicine, R&D | Option exercise · Restricted Share Units | −25,255 | 25,255 | ||
| 2025-04-24 | Woods Eugene A. Director | Grant or award · Deferred Share Units | +1,316 | 4,329.66 | ||
| 2025-04-24 | West Nadja Director | Grant or award · Deferred Share Units | +1,316 | 6,572.61 | ||
| 2025-04-24 | WEINBERGER MARK A Director | Grant or award · Deferred Share Units | +1,316 | 10,737.36 | ||
| 2025-04-24 | McClellan Mark B. Director | Grant or award · Deferred Share Units | +1,316 | 19,755.23 | ||
| 2025-04-24 | Joly Hubert Director | Grant or award · Deferred Share Units | +1,316 | 7,986.91 | ||
| 2025-04-24 | Johnson Paula A Director | Grant or award · Deferred Share Units | +1,316 | 4,265.98 | ||
| 2025-04-24 | HEWSON MARILLYN A Director | Grant or award · Deferred Share Units | +1,316 | 13,006.95 | ||
| 2025-04-24 | Beckerle Mary C Director | Grant or award · Deferred Share Units | +1,316 | 15,395.4 | ||
| 2025-04-24 | Doudna Jennifer A Director | Grant or award · Deferred Share Units | +1,316 | 9,656.14 | ||
| 2025-03-18 | Duato Joaquin CEO and Chairman of the Board | Gift | −130,852 | 275,967 |
Page 15 of 19 · 365 trades